Navigation Links
Inhibiting proteins may prevent cartilage breakdown in arthritis patients
Date:2/18/2009

earchers identified an active site in the SAF-1 protein molecule that is involved in the interaction with AP-1 to induce the expression of the MMP-1 gene.

"In this study, we looked at how and why MMP-1 is activated, particularly in the disease condition," Ray said. "Once we understand how this gene is activated, we can design drugs to control pathways to reduce the severity of MMP-1-mediated cartilage destruction. We found strong evidence that by blocking SAF-1, MMP-1 expression is inhibited. Now, we will continue to explore the interacting domain of SAF-1 as a possible contact point for competitive inhibition."


'/>"/>

Contact: Kelsey Jackson
JacksonKN@missouri.edu
573-882-8353
University of Missouri-Columbia
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Tumor-inhibiting protein could be effective in treating leukemia
2. Researchers find cancer-inhibiting compound under the sea
3. LSUHSC awarded patent for compound inhibiting cancer and other diseases
4. The bonsai effect: Wounded plants make jasmonates, inhibiting cell division, stunting growth
5. Researchers identify proteins involved in new neurodegenerative syndrome
6. NIH awards researcher $1.5 million new innovator grant for fruit-fly studies of prion proteins
7. Depression, aging, and proteins made by a virus may all play role in heart disease
8. New approach builds better proteins inside a computer
9. Legionnaires bacterial proteins work together to survive
10. Proteins pack tighter in crowded native state
11. MIT IDs proteins key to brain function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... -- MODA Technology Partners, a global software company ... testing for the Pharmaceutical industry, today announced the ... generation mobile data acquisition platform. The latest release ... their regulated manufacturing processes. ,, MODA 3.0 ... Fully-Configurable Test Methods: Each test method in ...
(Date:12/13/2009)... Biologists have identified plant enzymes that may help to ... to use water more efficiently. The finding could help ... gases. , Plants take in the carbon dioxide they ... surface of leaves. But for each molecule of the ... these same openings. The pores can tighten to save ...
(Date:12/13/2009)... led by Yale University researchers has used nanosensors ... the first time. Their findings, which appear December ... Nature Nanotechnology , could dramatically simplify the way ... diseases. , The teamled by Mark ... Applied Science, and Tarek Fahmy, an associate professor ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Scientists use nanosensors for first time to measure cancer biomarkers in blood 2BioMarin to Present at the Thomas Weisel Partners Healthcare Conference 56001 1BioMarin to Present at the Thomas Weisel Partners Healthcare Conference 56001 2BioMarin to Present at the Baird Healthcare Conference 13799 1BioMarin to Present at the Baird Healthcare Conference 13799 2Kids Fight Cancer Announces 25th Annual Gala to Support Children 26apos 3Bs Memorial Hospital 55999 1Kids Fight Cancer Announces 25th Annual Gala to Support Children 26apos 3Bs Memorial Hospital 55999 2Kids Fight Cancer Announces 25th Annual Gala to Support Children 26apos 3Bs Memorial Hospital 55999 3
... Hopkins Children's Center scientists has identified and successfully tamed ... cystic fibrosis (CF), a genetic disorder that interferes with ... of cells. , Using a tool called RNA interference ... sent out by the rampant protein and prevented cell ...
... in causing cancers via activation of oncogenes. If scientists ... genetic material become amplified and how, oncologists and drug ... prevent the formation and growth of some tumors. Using ... Institute of Technology have discovered that the location of ...
... said one 3 and a half-year old child, born deaf but ... That's the most complex speech the child uttered during a testing ... In contrast, a child of the same age who had a ... the people goes to stand there with that noise and now ...
Other Biology News:Johns Hopkins lab scientists tame overactive CF protein 2Scientists uncover rules for gene amplification 2With cochlear implants, earlier use leads to better speech 2With cochlear implants, earlier use leads to better speech 3
(Date:12/14/2009)... Calif., Dec. 14 Nektar Therapeutics (Nasdaq: ... has been appointed to serve on its board ... industry leader with over 35 years of experience ... "Dennis brings to Nektar extensive industry perspective at ... Howard W. Robin, President and CEO of Nektar ...
(Date:12/11/2009)... -- Dendreon Corporation (Nasdaq: DNDN ) announced ... public offering have exercised in full their option ... stock at the public offering price of $24.75 ... increases the size of the offering to an ... Dendreon expects to receive net proceeds from the ...
(Date:12/11/2009)... -- Algeta ASA (OSE: ALGETA), the,cancer therapeutics ... in the,US, the Tulane Cancer Center, New ... III clinical study of Alpharadin in men ... that has metastasized to the skeleton. , ... in SYMptomatic Prostate CAncer) study is a,double-blind, ...
(Date:12/10/2009)... Dendreon Corporation (Nasdaq: DNDN ) announced ... of 15,000,000 shares of its common stock at a ... Dendreon also granted to the underwriters a 30-day option ... common stock to cover overallotments, if any. The ... subject to customary closing conditions. ,, J. P. Morgan ...
Breaking Biology Technology:Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3
... Madison, Wis. Mithridion , the University of ... has closed its first round of financing with $1.6 million, ... go toward buying lab equipment, hiring scientists and developing drug ... sustain the firm for about 18 months, and that he ...
... pending Illinois broadband legislation (20 ILCS 3921/10), which was ... the Universal Access to Broadband Services Act. Requires the ... maintain a map of broadband infrastructure in the state. ... be available for lease on a non-discriminatory basis to ...
... to a biotech company (it is priority #1, #2, and ... sense) companies are continually faced with the challenge of raising ... article will focus on venture capital financing results for 2005. ... from Burrill and Company's data. Burrill's perspective is more towards ...
Other Biology Technology:Mithridion raises $1.6M through angel networks 2Proposed Illinois broadband act falls short 2Proposed Illinois broadband act falls short 3Proposed Illinois broadband act falls short 4Proposed Illinois broadband act falls short 5U.S. VC funding flat in 2005 while life science funding grows 2U.S. VC funding flat in 2005 while life science funding grows 3U.S. VC funding flat in 2005 while life science funding grows 4
Request Info...
Request Info...
Request Info...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: